Back to mobile site

Morgan Stanley Reiterates Equalweight Rating on Johnson & Johnson (JNJ)

January 13, 2025 8:32 AM EST Send to a Friend
Morgan Stanley analyst Terrance Flynn reiterated an Equalweight rating and $175.00 price target on Johnson & Johnson (NYSE: JNJ)The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login